The safety of AVI-@ was evaluated in a randomized , multiple-ascending-dose study in which @ healthy humans ( @ humans per dose group ) received @ once-daily infusions of AVI-@ ( @ mg , @ mg , @ mg , @ mg , or @ mg per kilogram of body weight ) or placebo , in a @:@ ratio .